Background Annual influenza vaccination is recommended for health care workers (HCWs) in many countries in order to reduce the morbidity associated with influenza in health care settings. However, compliance rates with influenza vaccination are commonly low.
Aims
To evaluate the current vaccination status of HCWs in Beijing, China, and examine their attitudes towards the disease and the vaccine.
Methods
In January 2009, a survey was completed by 1909 HCWs in emergency departments, infection fever clinics, respiratory ward/outpatient's clinics and pediatric medical departments of 24 hospitals in Beijing (99% response rate).
Results
Respondents were categorized into three main groups by occupation: nursing (60%, n 5 1143), medical (36%, n 5 693) and other (4%, n 5 73). When examining beliefs about the influenza vaccine, 57% (n 5 1081) felt it was safe and 54% (n 5 1028) thought it was effective. Less than 18% stated that they had been immunized in 2008; 40% (n 5 765) or participants agreed with the statement 'the flu vaccine can cause flu in some people'.
Introduction
Every year, influenza epidemics are responsible for thousands of hospital admissions and hundreds of deaths. Influenza outbreaks are of particular concern in hospitals, nursing homes and other health care settings as most patients are prone to the complications of influenza [1] . Health care workers (HCWs) have been implicated in the transmission of the influenza virus to patients [2, 3] . In addition to the risk of transmitting influenza virus to patients, HCWs have an increased risk of exposure to influenza virus from patients, which can lead to illness, excessive absenteeism and disruption of the health care system during epidemics [4, 5] .
Vaccination of HCWs has been associated with reductions in influenza infections, respiratory illness and lost workdays amongst hospital HCWs and in mortality and influenza-like illness amongst residents in long-term care facilities [6, 7] . To reduce or prevent the spread of influenza in health care facilities, the Advisory Committee on Immunization Practices in the USA has recommended annual influenza immunization for HCWs who have direct patient contact [8] . Despite these recommendations, only 36% of HCWs in the USA are vaccinated against influenza annually [8] . Other previous studies demonstrate a range of influenza immunization rates for overseas doctors from 38 to 82% [9, 10] .
Influenza vaccine is not widely used in China, and there is low awareness about the value of this vaccine. The Beijing CDC Prevention and Control of Influenza Technical Guidance Handout ranks the influenza vaccine as a 'second-class vaccine' (Q. Wang, personal communication); therefore, citizens have to acquire it at their own expense. In Beijing, if the hospitals do not provide the vaccine, it may be the case HCWs are unlikely to seek it elsewhere.
The aim of this study was to evaluate the current vaccination status of HCWs in Beijing, China, and examine their attitudes towards the disease and the vaccine.
Methods
Between the 16th and 29th of January 2009, we conducted a survey in 24 hospitals in Beijing to evaluate the current vaccination status of HCWs and their knowledge and attitudes towards the disease and the vaccine. We surveyed HCWs at the end of their participation in a prospective, four-armed cluster randomized trial (RCT). Enrolment in the RCT was restricted to hospital HCWs from the emergency departments, infection fever clinics, respiratory wards and respiratory outpatient's clinics and paediatric medical departments of 24 hospitals. These wards were selected because they are a setting in which repeated and multiple exposures to viral respiratory infections are expected for staff.
The Ministry of Health in 1989 categorizes hospitals in China into three levels (Level 3 is the highest) depending on their level of sophistication, equipment and staff/bed numbers. In the trial, only hospitals classified as Levels 2 and 3 were included. Traditional Chinese Medicine Hospitals and specialist units such as gynaecology and obstetrics hospitals were excluded. All the hospitals were public and were within a 10-km radius of the centre of the city.
We developed an anonymous 2-page, tick box, closed question-designed survey, in Mandarin, that assessed the following: (i) demographic characteristics, family situation and workplace specialty; (ii) their attitudes towards the disease and the vaccine and (iii) uptake of the influenza vaccine. Prior to the commencement of the study, we interviewed the head of each participating department/ ward to assess hospital infection control practices and the provision of the influenza vaccine. The survey was based on a previous survey undertaken on a sample of HCWs in Australia.
In addition to surveying the hospital staff, we also distributed a self-administered questionnaire to doctorsin-charge or nurse managers working in the same 24 hospitals as the HCWs surveyed. This survey included questions on hospital infection control levels and practices including seasonal influenza vaccination.
Univariate analysis including crude odds ratios, P values and chi-squared test for differences was performed using EpiInfo (version 3.3.2) CDC (Atlanta, GA). Alpha was set at the 5% level. Ethical approval was sought and granted from the Institutional Review Board and Human Research Ethics Committee of the Beijing Centre for Disease Prevention and Control.
Results
Of the 1936 HCWs who were provided with a survey, 1909 completed it (response rate: 99%). Table 1 summarizes the demographic data for respondents. Influenza vaccine was stable at 18% in 2008 and 2009. Nurses reported the highest level of uptake (21%), followed by doctors (13%); 10 of the 24 hospitals had a vaccination rate of #10%, whilst a further 7 hospitals had a range between 20 and 30%. The vaccine uptake in the hospitals ranged from 1.3 to 52%, with staff from the infection clinics having the highest rates of vaccine uptake (n 5 50, 39%).
When examining beliefs about the influenza vaccine, 57% (n 5 1081) felt it was safe and 54% thought it was effective (n 5 1028); 13% (n 5 249) of respondents felt that the vaccine was unsafe. Of the staff who stated they felt the influenza vaccine was safe and effective, 61% (n 5 208) and 59% (n 5 203), respectively, reported receiving it (Table 2) .
Slightly more staff stated that it was more important to be vaccinated against influenza for the protection of family (56%) than patients (52%). For staff who felt it was important to vaccinate for the protection of family and patients, 62 and 58% (n 5 199) reported receiving the vaccine in 2008, respectively. Only 19% of staff agreed with the statement 'I am at low risk of catching flu'; 40% agreed with the statement 'the flu vaccine can cause flu in some people', whilst a further 35% were unsure and 25% disagreed.
In univariate analysis, factors significantly associated with being vaccinated included working in either the emergency department, believing that the influenza vaccine was effective and lastly believing that the vaccine was important for the protection of patients or family members (Table 3) . Prior to the commencement of this study, we interviewed the head of each department/ward to ascertain whether the influenza vaccine was provided to staff. Information was collected from all 76 department/wards. While we cannot link the information from the interviews to the survey, we did find that 43 wards stated that they did not supply vaccine, 23 wards supplied vaccine to both doctors and nurses, 8 vaccinated just nurses and the remaining 2 vaccinated only the doctors.
Discussion
This survey found a vaccination rate for seasonal influenza in HCWs in Beijing of 18%. This is lower than rates reported in Italy (20%) [11] , France (21%) [12] , Australia (22%) [13] , USA (36%) [8] , but more than Spain (10%) [14] . The rate of vaccine uptake in this cohort is also much lower when compared with other cohorts of Asian HCWs. For example, Tam et al. [15] found that vaccination rates in 2006 and 2007 were 57 and 46%, respectively, for a cohort of 941 nurses registered at three nursing associations in Hong Kong. Lastly, Chan et al. [16] showed a vaccination rate amongst Taiwanese HCWs of almost 100%.
There are a number of limitations to this study. Firstly, as this study was based on self-reported data, it has certain weaknesses that may serve as sources of bias in data interpretation. Secondly, the study sample was limited to those HCWs who participated in the RCT. As the study includes hospital HCWs from four districts of Beijing only, it does not account for potential jurisdictional or regional variations nationwide. Also, although the participating departments differed in setting and patient population, they might not be representative for all other hospitals and departments. Lastly, and most significantly, we were unable to obtain protocols from each of the hospitals regarding their vaccine policies that prevented interpretation of survey responses within the context of the vaccination regime in place in the individual respondent's workplace. In our study, we found that nurses had a higher level of reported vaccine uptake than doctors. This finding is not consistent with previous studies, which have reported that physicians consistently comply better with influenza vaccination than other HCW groups [12] . Previous studies exploring the reasons given for vaccine refusal have found that physicians are more likely to report that they are too busy to get vaccinated [9, 17] , whereas other HCWs including nurses are non-compliant because of confidence in their health or doubts about vaccine efficacy or concerns over side effects [18] . While we did not assess reasons for vaccine refusal directly, it can be hypothesized that factors other than vaccine concerns are contributing to the low rate in our cohort. In a recent review of studies on attitudes and predictors of influenza vaccination of HCWs in hospitals [19] , the top five reasons for refusing the vaccine were 'fear of adverse reactions', 'lack of concern', 'inconvenient delivery', 'lack of perception of own risk' and 'doubts about vaccine efficacy'.
The false belief that the vaccine can cause influenza persisted among 35% of our cohort, despite a general perception about its safety. This result is comparable to other studies that have reported frequencies from 30 to 45% [20, 21] . In our study, we found that only 14% of respondents perceived that the vaccine was ineffective, whereas in a study by Goldstein et al. 67% of hospital respondents agreed with a statement that the vaccine was ineffective [22] . These findings suggest that additional education about the influenza vaccine is needed including information on (i) the proven efficacy against influenza, (ii) vaccine development and testing and (iii) the potential adverse reactions. Providing this information could theoretically build the basis for acceptance of vaccination.
A number of institutions have found effective strategies to increase the rate of influenza vaccination amongst HCWs. In some cases, mobile carts have been successfully used to take free vaccine to the work areas on all work shifts [23] . In other centres, reminder-recall systems, designated influenza vaccination days, vaccination at grand rounds, vaccination of supervisors in front of employees or the assignment of one or more occupational nurses to organize a vaccination campaign have been proven to be effective [24] . In our setting, increasing the available of free vaccine to the staff may have an effect on the levels of uptake. Also, highlighting the importance of the vaccine in protecting not only the HCW but also their patients may boost uptake amongst this cohort of Chinese HCWs.
Influenza remains a major cause of illness for the elderly and other high-risk patients cared for by physicians and nurses. While vaccination rates remain low, HCWs may serve as an important source of infection. To improve vaccination rates in this setting, governments and hospital administrators must ensure that vaccine is offered conveniently and at low cost to the staff. Conflicts of interest C.R.M. receives funding from influenza vaccine manufacturers GlaxoSmithKline and CSL Biotherapies for investigator-driven research. The remaining authors declare that they have no competing interests.
